110 related articles for article (PubMed ID: 38852112)
1. Genotypes and phenotypes of motor neuron disease: an update of the genetic landscape in Scotland.
Leighton DJ; Ansari M; Newton J; Cleary E; Stephenson L; Beswick E; Carod Artal J; Davenport R; Duncan C; Gorrie GH; Morrison I; Swingler R; Deary IJ; Porteous M; Chandran S; Pal S;
J Neurol; 2024 Jun; ():. PubMed ID: 38852112
[TBL] [Abstract][Full Text] [Related]
2. Genotype-phenotype characterisation of long survivors with motor neuron disease in Scotland.
Leighton DJ; Ansari M; Newton J; Parry D; Cleary E; Colville S; Stephenson L; Larraz J; Johnson M; Beswick E; Wong M; Gregory J; Carod Artal J; Davenport R; Duncan C; Morrison I; Smith C; Swingler R; Deary IJ; Porteous M; Aitman TJ; Chandran S; Gorrie GH; Pal S; ;
J Neurol; 2023 Mar; 270(3):1702-1712. PubMed ID: 36515702
[TBL] [Abstract][Full Text] [Related]
3. Genetic epidemiology of motor neuron disease-associated variants in the Scottish population.
Black HA; Leighton DJ; Cleary EM; Rose E; Stephenson L; Colville S; Ross D; Warner J; Porteous M; Gorrie GH; Swingler R; Goldstein D; Harms MB; Connick P; Pal S; Aitman TJ; Chandran S
Neurobiol Aging; 2017 Mar; 51():178.e11-178.e20. PubMed ID: 28089114
[TBL] [Abstract][Full Text] [Related]
4. Genetics screening in an Italian cohort of patients with Amyotrophic Lateral Sclerosis: the importance of early testing and its implication.
Libonati L; Cambieri C; Colavito D; Moret F; D'Andrea E; Del Giudice E; Leon A; Inghilleri M; Ceccanti M
J Neurol; 2024 Apr; 271(4):1921-1936. PubMed ID: 38112783
[TBL] [Abstract][Full Text] [Related]
5. Spectrum and frequency of genetic variants in sporadic amyotrophic lateral sclerosis.
Ruf WP; Boros M; Freischmidt A; Brenner D; Grozdanov V; de Meirelles J; Meyer T; Grehl T; Petri S; Grosskreutz J; Weyen U; Guenther R; Regensburger M; Hagenacker T; Koch JC; Emmer A; Roediger A; Steinbach R; Wolf J; Weishaupt JH; Lingor P; Deschauer M; Cordts I; Klopstock T; Reilich P; Schoeberl F; Schrank B; Zeller D; Hermann A; Knehr A; Günther K; Dorst J; Schuster J; Siebert R; Ludolph AC; Müller K
Brain Commun; 2023; 5(3):fcad152. PubMed ID: 37223130
[TBL] [Abstract][Full Text] [Related]
6. Relationship between neuropsychiatric disorders and cognitive and behavioural change in MND.
McHutchison CA; Leighton DJ; McIntosh A; Cleary E; Warner J; Porteous M; Chandran S; Pal S; Abrahams S
J Neurol Neurosurg Psychiatry; 2020 Mar; 91(3):245-253. PubMed ID: 31871139
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72.
Chiò A; Borghero G; Restagno G; Mora G; Drepper C; Traynor BJ; Sendtner M; Brunetti M; Ossola I; Calvo A; Pugliatti M; Sotgiu MA; Murru MR; Marrosu MG; Marrosu F; Marinou K; Mandrioli J; Sola P; Caponnetto C; Mancardi G; Mandich P; La Bella V; Spataro R; Conte A; Monsurrò MR; Tedeschi G; Pisano F; Bartolomei I; Salvi F; Lauria Pinter G; Simone I; Logroscino G; Gambardella A; Quattrone A; Lunetta C; Volanti P; Zollino M; Penco S; Battistini S; ; Renton AE; Majounie E; Abramzon Y; Conforti FL; Giannini F; Corbo M; Sabatelli M
Brain; 2012 Mar; 135(Pt 3):784-93. PubMed ID: 22366794
[TBL] [Abstract][Full Text] [Related]
8. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study.
Byrne S; Elamin M; Bede P; Shatunov A; Walsh C; Corr B; Heverin M; Jordan N; Kenna K; Lynch C; McLaughlin RL; Iyer PM; O'Brien C; Phukan J; Wynne B; Bokde AL; Bradley DG; Pender N; Al-Chalabi A; Hardiman O
Lancet Neurol; 2012 Mar; 11(3):232-40. PubMed ID: 22305801
[TBL] [Abstract][Full Text] [Related]
9. Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study.
van Blitterswijk M; DeJesus-Hernandez M; Niemantsverdriet E; Murray ME; Heckman MG; Diehl NN; Brown PH; Baker MC; Finch NA; Bauer PO; Serrano G; Beach TG; Josephs KA; Knopman DS; Petersen RC; Boeve BF; Graff-Radford NR; Boylan KB; Petrucelli L; Dickson DW; Rademakers R
Lancet Neurol; 2013 Oct; 12(10):978-88. PubMed ID: 24011653
[TBL] [Abstract][Full Text] [Related]
10. Cerebellar c9RAN proteins associate with clinical and neuropathological characteristics of C9ORF72 repeat expansion carriers.
Gendron TF; van Blitterswijk M; Bieniek KF; Daughrity LM; Jiang J; Rush BK; Pedraza O; Lucas JA; Murray ME; Desaro P; Robertson A; Overstreet K; Thomas CS; Crook JE; Castanedes-Casey M; Rousseau L; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Boeve BF; Graff-Radford NR; Rademakers R; Lagier-Tourenne C; Edbauer D; Cleveland DW; Dickson DW; Petrucelli L; Boylan KB
Acta Neuropathol; 2015 Oct; 130(4):559-73. PubMed ID: 26350237
[TBL] [Abstract][Full Text] [Related]
11. Ataxin-2 as potential disease modifier in C9ORF72 expansion carriers.
van Blitterswijk M; Mullen B; Heckman MG; Baker MC; DeJesus-Hernandez M; Brown PH; Murray ME; Hsiung GY; Stewart H; Karydas AM; Finger E; Kertesz A; Bigio EH; Weintraub S; Mesulam M; Hatanpaa KJ; White CL; Neumann M; Strong MJ; Beach TG; Wszolek ZK; Lippa C; Caselli R; Petrucelli L; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Mackenzie IR; Seeley WW; Grinberg LT; Miller BL; Boylan KB; Graff-Radford NR; Boeve BF; Dickson DW; Rademakers R
Neurobiol Aging; 2014 Oct; 35(10):2421.e13-7. PubMed ID: 24866401
[TBL] [Abstract][Full Text] [Related]
12. Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72.
Cooper-Knock J; Hewitt C; Highley JR; Brockington A; Milano A; Man S; Martindale J; Hartley J; Walsh T; Gelsthorpe C; Baxter L; Forster G; Fox M; Bury J; Mok K; McDermott CJ; Traynor BJ; Kirby J; Wharton SB; Ince PG; Hardy J; Shaw PJ
Brain; 2012 Mar; 135(Pt 3):751-64. PubMed ID: 22366792
[TBL] [Abstract][Full Text] [Related]
13. Genetic variability in sporadic amyotrophic lateral sclerosis.
Van Daele SH; Moisse M; van Vugt JJFA; Zwamborn RAJ; van der Spek R; van Rheenen W; Van Eijk K; Kenna K; Corcia P; Vourc'h P; Couratier P; Hardiman O; McLaughin R; Gotkine M; Drory V; Ticozzi N; Silani V; Ratti A; de Carvalho M; Mora Pardina JS; Povedano M; Andersen PM; Weber M; Başak NA; Shaw C; Shaw PJ; Morrison KE; Landers JE; Glass JD; van Es MA; van den Berg LH; Al-Chalabi A; Veldink J; Van Damme P
Brain; 2023 Sep; 146(9):3760-3769. PubMed ID: 37043475
[TBL] [Abstract][Full Text] [Related]
14. Phenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genes.
Millecamps S; Boillée S; Le Ber I; Seilhean D; Teyssou E; Giraudeau M; Moigneu C; Vandenberghe N; Danel-Brunaud V; Corcia P; Pradat PF; Le Forestier N; Lacomblez L; Bruneteau G; Camu W; Brice A; Cazeneuve C; Leguern E; Meininger V; Salachas F
J Med Genet; 2012 Apr; 49(4):258-63. PubMed ID: 22499346
[TBL] [Abstract][Full Text] [Related]
15. Prospective observational cohort study of factors influencing trial participation in people with motor neuron disease (FIT-participation-MND): a protocol.
Beswick E; Glasmacher SA; Dakin R; Newton J; Carson A; Abrahams S; Chandran S; Pal S
BMJ Open; 2021 Mar; 11(3):e044996. PubMed ID: 33757953
[TBL] [Abstract][Full Text] [Related]
16. Analysis of
Kekenadze M; Rocca C; Turchetti V; Nagy S; Kvirkvelia N; Vashadze S; Kvaratskhelia E; Beridze M; Kaiyrzhanov R; Houlden H
F1000Res; 2023; 12():1113. PubMed ID: 38464738
[TBL] [Abstract][Full Text] [Related]
17. Mild motor impairment as prodromal state in amyotrophic lateral sclerosis: a new diagnostic entity.
Benatar M; Granit V; Andersen PM; Grignon AL; McHutchison C; Cosentino S; Malaspina A; Wuu J
Brain; 2022 Oct; 145(10):3500-3508. PubMed ID: 35594156
[TBL] [Abstract][Full Text] [Related]
18. Frequency of C9orf72 hexanucleotide repeat expansion and SOD1 mutations in Portuguese patients with amyotrophic lateral sclerosis.
Gromicho M; Pinto S; Gisca E; Pronto-Laborinho AC; Andersen PM; de Carvalho M
Neurobiol Aging; 2018 Oct; 70():325.e7-325.e15. PubMed ID: 29861044
[TBL] [Abstract][Full Text] [Related]
19. An MND/ALS phenotype associated with C9orf72 repeat expansion: abundant p62-positive, TDP-43-negative inclusions in cerebral cortex, hippocampus and cerebellum but without associated cognitive decline.
Troakes C; Maekawa S; Wijesekera L; Rogelj B; Siklós L; Bell C; Smith B; Newhouse S; Vance C; Johnson L; Hortobágyi T; Shatunov A; Al-Chalabi A; Leigh N; Shaw CE; King A; Al-Sarraj S
Neuropathology; 2012 Oct; 32(5):505-14. PubMed ID: 22181065
[TBL] [Abstract][Full Text] [Related]
20. Temporal course of cognitive and behavioural changes in motor neuron diseases.
McHutchison CA; Wuu J; McMillan CT; Rademakers R; Statland J; Wu G; Rampersaud E; Myers J; Hernandez JP; Abrahams S; Benatar M;
J Neurol Neurosurg Psychiatry; 2024 Mar; 95(4):316-324. PubMed ID: 37827570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
